CloudTMSRecalls & reported problems
Neurosoft, Ooo · The CloudTMS system is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to receive satisfactory improvement from prior antidepressant medications in the current episode. The Cloud TMS stimulator is intended to be used as an adjunct for the treatment of adult patients suffering from Obsessive-Compulsive Disorder (OCD). · Class 2
Data updated Oct 13, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 04650075330296), received between Aug 21, 2025 and Aug 21, 2025 — classified as 1 injury.
The most frequently reported specific device problem is “Off-Label Use” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Reports received per month
Most reported problems
Device problems
- Off-Label Use1
Patient problems
- Convulsion/Seizure1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryAug 21, 2025Off-Label Use; Off-Label Use
ON (B)(6) 2025, THE CUSTOMER CONTACTED THE AUTHORIZED AGENT'S OFFICE TO TELL THAT SHE EXPERIENCED A SEIZURE WHILE TREATING HERSELF WITH THE MACHINE, USING AN UNKNOWN PROTOCOL THAT, ACCORDING TO HER, WAS DESIGNED BY ONE OF HER FRIENDS. THE CUSTOMER SENT A VIDEO OF THAT INCIDENT, THE VIDEO BEING DATED (B)(6) 2025, SHOWING SHE WAS ADMINISTERING THAT TREATMENT TO HERSELF, WITH NO ONE SEEN IN THE ROOM WITH HER. SHE IS SEEN STANDING UP WITH THE COIL ON HER HEAD AND THEN FALLING DOWN AND GOING OUT OF CAMERA VIEW, SO THERE WAS NO CONFIRMATION BY VIDEO RECORDING, OR BY ANY OBSERVER OF WHAT HAPPENED DURING OR AFTER THE FALL. ON (B)(6) 2025, THE CUSTOMER EMAILED THE AUTHORIZED AGENT TELLING THAT SHE HAD BEEN TAKEN TO THE EMERGENCY ROOM AFTER THE FALL, AND WAS DISCHARGED WITH "SEIZURE AND CONCUSSION PRECAUTIONS", BUT THERE WAS NO MENTION IN HER EMAIL OF ANY EXAM FOR SEIZURES OR EEG RECORDING DURING HER EMERGENCY ROOM VISIT. THE CUSTOMER RETURNED THE MACHINE AND ITS LAPTOP, WHERE IT WAS WITNESSED THAT SHE HAD INSTALLED A TMS PROTOCOL THAT WAS NOT INCLUDED IN HER LAPTOP PRIOR TO SHIPMENT. ONCE THE MACHINE WAS BACK, IT WAS COMPLETELY CHECKED, ITS FUNCTIONING WAS TESTED AND IT WAS FOUND THAT THE D
Patient problems: Convulsion/Seizure
MAUDE report 22861152 ↗
Other Transcranial Magnetic Stimulator devices
- NeuroStar TMS Therapy System NeuroStar 3.0 USNeuronetics, Inc. · Transcranial Magnetic Stimulator58 reports
- NeuroStar Advanced Therapy System Version 3.7Neuronetics, Inc. · Transcranial Magnetic Stimulator13 reports
- NeuroStar Advanced Therapy System Version 3.8Neuronetics, Inc. · Transcranial Magnetic Stimulator12 reports
- NeuroStar Advanced Therapy System Version 3.6Neuronetics, Inc. · Transcranial Magnetic Stimulator8 reports
- Deep Transcranial Magnetic Stimulation (DTMS) System 104Brainsway Ltd · Transcranial Magnetic Stimulator5 reports
- NeuroStar Advanced Therapy System 3.XNeuronetics, Inc. · Transcranial Magnetic Stimulator3 reports
- NeuroStar TMS Therapy System NeuroStar 2.0 USNeuronetics, Inc. · Transcranial Magnetic Stimulator2 reports
- NeuroStar Advanced Therapy System Version 3.7Neuronetics, Inc. · Transcranial Magnetic Stimulator1 report
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 13, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 13, 2026
- Page last rebuilt: Oct 13, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page